AMP-K vs Icotrokinra
Overview
AMP-K and Icotrokinra are both immune support peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares AMP-K and Icotrokinra across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| AMP-K | Icotrokinra | |
|---|---|---|
| Category | Immune Support | Immune Support |
| Regulatory status (US) | Research use only | FDA approved |
| Typical dosage | 100-200 mg | — |
| Frequency | daily | — |
| Reported benefits | Metabolic support, immune enhancement, cellular energy | — |
| Reported side effects | Generally safe | — |
Key differences
Primary use. AMP-K is categorised under Immune Support, while Icotrokinra falls under Immune Support. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. AMP-K: not FDA-approved; treated as a research compound. Icotrokinra: FDA-approved.
Dosing. AMP-K is typically dosed at 100-200 mg (daily). Typical dosing for Icotrokinra is not catalogued.
Can you stack them?
Some protocols combine peptides, but stacking AMP-K and Icotrokinra has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between AMP-K and Icotrokinra?
- AMP-K and Icotrokinra are both immune support peptides, but they differ in mechanism, dosing, and regulatory status. AMP-K is not FDA-approved; generally classified as a research compound, whereas Icotrokinra is FDA-approved for one or more indications.
- What is AMP-K used for?
- Metabolic immune support.
- What is Icotrokinra used for?
- Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.
- Can you take AMP-K and Icotrokinra together?
- Some users combine peptides within a single protocol, but stacking AMP-K and Icotrokinra has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is AMP-K or Icotrokinra FDA-approved?
- AMP-K is not FDA-approved; generally classified as a research compound. Icotrokinra is FDA-approved for one or more indications.
Read the full articles
- AMP-K — full monograph: mechanism, research, dosing & references
- Icotrokinra — full monograph: mechanism, research, dosing & references